Taiyen Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
May 03, 2023 at 02:46 am EDT
Share
Taiyen Biotech Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 865 million compared to TWD 923.15 million a year ago. Net income was TWD 108.13 million compared to TWD 127.24 million a year ago.
Basic earnings per share from continuing operations was TWD 0.54 compared to TWD 0.64 a year ago. Diluted earnings per share from continuing operations was TWD 0.54 compared to TWD 0.64 a year ago.
Taiyen Biotech Co., Ltd is a Taiwan-based company mainly engaged in the manufacture, distribution and trading of salt products, salt by-products and other salt derivatives. The Company offers salt products, skin care and cosmetics, bottled water products, facial and body cleansers, health and dietary supplements, as well as other products, such as collagen raw materials, biomedical materials, microbial agents and others. The Companyâs salt products include fine salts, dried salts, low sodium salts, bay salts and other salts, which are applied in industry, agriculture, food processing, cooking and others. The Company distributes its products in Taiwan market and to overseas markets.